These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1857007)

  • 21. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
    JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute intermittent porphyria in The Netherlands. Heterogeneity of the enzyme porphobilinogen deaminase.
    Wilson JH; De Rooy FW; Te Velde K
    Neth J Med; 1986; 29(11):393-9. PubMed ID: 3808142
    [No Abstract]   [Full Text] [Related]  

  • 23. Porphobilinogen-synthase (delta-aminolevulinic acid dehydratase) deficiency in bone marrow cells of two patients with porphobilinogen-synthase defect acute porphyria.
    Doss M; Tiepermann RV; Schneider J
    Klin Wochenschr; 1983 Jul; 61(14):699-702. PubMed ID: 6887758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The measurement of erythrocyte uroporphyrinogen 1 synthase in the diagnosis of latent and acute intermittent porphyria.
    Brocklehurst D; Wider de Xifra EA; Batlle A
    Int J Biochem; 1980; 12(5-6):791-3. PubMed ID: 7450134
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte uroporphyrinogen-I-synthetase activity in acute intermittent porphyria.
    Wilson JH; van den Berg JW; Brouwers D; Coppens K; van Zellem J
    Neth J Med; 1979; 22(1):13-6. PubMed ID: 418940
    [No Abstract]   [Full Text] [Related]  

  • 28. [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria].
    Kostrzewska E; Gregor A
    Pol Tyg Lek; 1980 Nov; 35(46):1785-6. PubMed ID: 7243643
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of a homogeneous formula high in corn oil and of intravenous glucose on red cell uroporphyrinogen I synthetase activity during porphyric relapses.
    Haust HL; McCourtie DR; Ali H
    Int J Biochem; 1980; 12(5-6):811-8. PubMed ID: 7004932
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intermittent acute porphyria (author's transl)].
    Clotet B; Pérez C; Martinez-Vázquez JM
    Med Clin (Barc); 1979 Jun; 73(1):32-8. PubMed ID: 470503
    [No Abstract]   [Full Text] [Related]  

  • 31. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE; Ou CN; Ellefson RD
    Clin Chem; 1980 Jul; 26(8):1182-5. PubMed ID: 7389090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda.
    Doss MO
    Eur J Clin Invest; 1989 Feb; 19(1):20-5. PubMed ID: 2499457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of acute intermittent porphyria with laevulose.
    Brodie MJ; Moore MR; Thompson GG; Goldberg A
    Clin Sci Mol Med; 1977 Oct; 53(4):365-71. PubMed ID: 913061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic studies of families of patients with porphyria. Determination of uroporphyrinogen I synthase in the erythrocytes].
    Gregor A; Kostrzewska E; Kocyłowski M; Rudowski W
    Pol Arch Med Wewn; 1979 Jul; 62(1):15-21. PubMed ID: 503882
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute intermittent porphyria: uroporphyrinogen-I-synthetase activity in erythrocytes as a diagnostic index].
    Formgren B; Wetterberg L
    Lakartidningen; 1978 May; 75(19):1921-4. PubMed ID: 651454
    [No Abstract]   [Full Text] [Related]  

  • 38. [Letter: Determination of uroporphyrinogen I synthetase in intermittent acute porphyria. 7 cases].
    Koehl C; Abecassis J; Wertenschlag J
    Nouv Presse Med; 1975 Nov; 4(38):2735. PubMed ID: 1202467
    [No Abstract]   [Full Text] [Related]  

  • 39. Reference values of 5-aminolevulinate dehydrase and porphobilinogen deaminase in the Spanish population from Madrid.
    Santos JL; Fontanellas A; Batlle AM; Enríquez de Salamanca RE
    Ecotoxicol Environ Saf; 1998 Mar; 39(3):168-71. PubMed ID: 9570906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology and diagnosis of acute intermittent porphyria].
    Wichmann T; Freye HA
    Z Gesamte Inn Med; 1977 Jun; 32(12):289-92. PubMed ID: 910533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.